======= RUFY3 ======= == Gene Information == * **Official Symbol**: RUFY3 * **Official Name**: RUN and FYVE domain containing 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22902|22902]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7L099|Q7L099]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RUFY3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RUFY3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611194|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a RPIP8, UNC-14, and NESCA domain-containing protein that is required for maintenance of neuronal polarity. In addition, it has been implicated in mediation of gastric cancer cell migration and invasion via interaction with P21-activated kinase-1, which promotes its expression. The encoded protein localizes to F-actin-enriched invadopodia to induce formation of protrusions, thereby facilitating cell migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]. * **UniProt Summary**: Plays a role in the generation of neuronal polarity formation and axon growth (By similarity). Implicated in the formation of a single axon by developing neurons (By similarity). May inhibit the formation of additional axons by inhibition of PI3K in minor neuronal processes (By similarity). Plays a role in the formation of F-actin-enriched protrusive structures at the cell periphery (PubMed:25766321). Plays a role in cytoskeletal organization by regulating the subcellular localization of FSCN1 and DBN1 at axonal growth cones (By similarity). Promotes gastric cancer cell migration and invasion in a PAK1-dependent manner (PubMed:25766321). {ECO:0000250|UniProtKB:Q5FVJ0, ECO:0000250|UniProtKB:Q9D394, ECO:0000269|PubMed:25766321}. |RUN| |FYVE| |invadopodium| |regulation of establishment of cell polarity| |regulation of establishment or maintenance of cell polarity| |positive regulation of axon extension| |negative regulation of axonogenesis| |filopodium| |endomembrane system| |positive regulation of axonogenesis| |regulation of axon extension| |negative regulation of cell morphogenesis involved in differentiation| |regulation of extent of cell growth| |growth cone| |perikaryon| |positive regulation of intracellular protein transport| |negative regulation of neuron projection development| |positive regulation of cell morphogenesis involved in differentiation| |positive regulation of cell growth| |positive regulation of developmental growth| |lamellipodium| |negative regulation of cell projection organization| |regulation of cell size| |regulation of axonogenesis| |positive regulation of intracellular transport| |negative regulation of neuron differentiation| |regulation of intracellular protein transport| |actin filament organization| |positive regulation of growth| |positive regulation of neuron projection development| |negative regulation of neurogenesis| |axon| |regulation of cell morphogenesis involved in differentiation| |negative regulation of nervous system development| |positive regulation of cellular protein localization| |regulation of developmental growth| |negative regulation of cell development| |regulation of intracellular transport| |positive regulation of neuron differentiation| |neuronal cell body| |regulation of cellular component size| |positive regulation of cell projection organization| |regulation of cell growth| |dendrite| |positive regulation of protein transport| |supramolecular fiber organization| |positive regulation of establishment of protein localization| |positive regulation of neurogenesis| |regulation of cell morphogenesis| |actin cytoskeleton organization| |regulation of neuron projection development| |positive regulation of cell migration| |regulation of anatomical structure size| |positive regulation of cell motility| |positive regulation of nervous system development| |positive regulation of cellular component movement| |regulation of cellular protein localization| |positive regulation of cell development| |cell junction| |positive regulation of locomotion| |actin filament-based process| |regulation of neuron differentiation| |regulation of growth| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of neurogenesis| |regulation of cell migration| |regulation of cell motility| |regulation of cellular localization| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |positive regulation of cell differentiation| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |regulation of protein localization| |regulation of anatomical structure morphogenesis| |cytoskeleton organization| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |positive regulation of developmental process| |generation of neurons| |neurogenesis| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |regulation of transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp518|RK-33 8μM R08 exp518]]|-2.09| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|1.78| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|2.04| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|2.05| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|2.17| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|2.24| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|2.31| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|2.38| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.39| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13452 * **Expression level (log2 read counts)**: 4.3 {{:chemogenomics:nalm6 dist.png?nolink |}}